Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Alkahest Appoints Key Executives | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Alkahest Appoints Key Executives

The two new hires bring along over 40 decades of combined experience

By: Betsy Louda

, Contract Pharma

Alkahest announced the appointments of Karl G. Trass as vice president of Regulatory Affairs and Jonas Hannestad, M.D., Ph.D. as senior medical director. 

 

“We are delighted to further expand our development team as we work to bring innovative medicines to patients with Alzheimer’s Disease, Parkinson’s Disease and other serious diseases of aging,” said Helen Jenkins, Alkahest’s chief operating officer.

 

Karl brings to Alkahest more than 20 years of experience providing global regulatory strategic leadership in both pharmaceutical and biotechnology companies. He joins the company from Tobira Therapeutics where he was also vice president of Regulatory Affairs. 

 

Jonas also has more than 20 years of experience in the field of neuroscience at both academic and biopharmaceutical organizations and is a noted authority in PET imaging in neuroinflammatory and other neurological disorders including the effect of systemic factors on the brain. Dr. Hannestad will maintain his appointment as Adjunct Assistant Professor of Psychiatry at the Yale University School of Medicine, and will be responsible for Alkahest’s clinical programs in Alzheimer’s and Parkinson’s Disease. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics